if CDY we compare with HTX who is in the early stages of developing a 2 BiomarkerS (AGR2 and HTX010) to detect a Ovarian Cancer and shares are trading at 9.3 c and at one stage reached 19.5 cents, CDY has a way more interesting product Midkine Blood test with great and wide potencial, its my thinking that shares in CDY are way to low at the moment.
only my thoughts
turnaround time, page-12
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable